224 related articles for article (PubMed ID: 28303429)
1. Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
Davis JL; Langan RC; Panageas KS; Zheng J; Postow MA; Brady MS; Ariyan C; Coit DG
Ann Surg Oncol; 2017 Jul; 24(7):1989-1996. PubMed ID: 28303429
[TBL] [Abstract][Full Text] [Related]
2. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
3. A high neutrophil to lymphocyte ratio prior to BRAF inhibitor treatment is a predictor of poor progression-free survival in patients with metastatic melanoma.
Finon A; Zaragoza J; Maillard H; Beneton N; Bens G; Samimi M; Caille A; Machet L
Eur J Dermatol; 2018 Feb; 28(1):38-43. PubMed ID: 29336315
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study.
Robinson AV; Keeble C; Lo MCI; Thornton O; Peach H; Moncrieff MDS; Dewar DJ; Wade RG
Cancer Immunol Immunother; 2020 Apr; 69(4):559-568. PubMed ID: 31974724
[TBL] [Abstract][Full Text] [Related]
5. High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy.
Bartlett EK; Flynn JR; Panageas KS; Ferraro RA; Sta Cruz JM; Postow MA; Coit DG; Ariyan CE
Cancer; 2020 Jan; 126(1):76-85. PubMed ID: 31584709
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Factor in Patients with Non-metastatic Renal Cell Carcinoma.
Wen RM; Zhang YJ; Ma S; Xu YL; Chen YS; Li HL; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(9):3703-8. PubMed ID: 25987025
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and Management of Thick and Ultrathick Melanoma.
Blakely AM; Cohen JT; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2019 Nov; 42(11):824-829. PubMed ID: 31517636
[TBL] [Abstract][Full Text] [Related]
9. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.
Ferrucci PF; Ascierto PA; Pigozzo J; Del Vecchio M; Maio M; Antonini Cappellini GC; Guidoboni M; Queirolo P; Savoia P; Mandalà M; Simeone E; Valpione S; Altomonte M; Spagnolo F; Cocorocchio E; Gandini S; Giannarelli D; Martinoli C
Ann Oncol; 2016 Apr; 27(4):732-8. PubMed ID: 26802161
[TBL] [Abstract][Full Text] [Related]
10. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery.
Malietzis G; Giacometti M; Askari A; Nachiappan S; Kennedy RH; Faiz OD; Aziz O; Jenkins JT
Ann Surg; 2014 Aug; 260(2):287-92. PubMed ID: 24096764
[TBL] [Abstract][Full Text] [Related]
11. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio in head and neck cancer.
Haddad CR; Guo L; Clarke S; Guminski A; Back M; Eade T
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):514-519. PubMed ID: 25908427
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
Ojerholm E; Smith A; Hwang WT; Baumann BC; Tucker KN; Lerner SP; Mamtani R; Boursi B; Christodouleas JP
Cancer; 2017 Mar; 123(5):794-801. PubMed ID: 27787873
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
16. High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.
Teterycz P; Jagodzińska-Mucha P; Cybulska-Stopa B; Mariuk-Jarema A; Kozak K; Koseła-Paterczyk H; Czarnecka AM; Rajczykowski M; Dziura R; Galus Ł; Mackiewicz J; Świtaj T; Klimczak A; Falkowski S; Suwiński R; Ziobro M; Ługowska I; Rutkowski P
Melanoma Res; 2018 Oct; 28(5):435-441. PubMed ID: 29782381
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma.
Yanagiya M; Nitadori JI; Nagayama K; Anraku M; Sato M; Nakajima J
Surg Today; 2018 Apr; 48(4):422-430. PubMed ID: 29063371
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-Lymphocyte Ratio: Prognostic Impact in Heart Surgery. Early Outcomes and Late Survival.
Silberman S; Abu-Yunis U; Tauber R; Shavit L; Grenader T; Fink D; Bitran D; Merin O
Ann Thorac Surg; 2018 Feb; 105(2):581-586. PubMed ID: 29132702
[TBL] [Abstract][Full Text] [Related]
19. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
